← Association for Accessible Medicines
FDANonrulemakingFDA-2024-D-2033

Expedited Program for Serious Conditions--Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Availability

RIN
—
Last modified
Jul 16, 2025
Comment window
closed 112d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Mar 4, 2025 and Mar 4, 2025. 0 other organizations filed here. The comment window closed 112d ago.

What Association for Accessible Medicines filed (1)

Mar 4, 2025· Comment from Association for Accessible Medicines (AAM)· FDA-2024-D-2033-0030

FDA, Please find attached comments from the Association for Accessible Medicines (AAM) regarding Docket No. FDA-2023-D-5016 "Expedited Program for Serious Conditions—Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry" Thanks, Scott Kuzner, Ph.D., Senior Director, Sciences and Regulatory Affairs, AAM

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →